Disease
|
Drug/Important Bio-Agent (IBA)
| 2 | Phorbol EstersIBA
11/2001
-
12/2000 |
| 2 | Protein Kinase CIBA
11/2001
-
12/2000 |
| 2 | Protein Isoforms (Isoforms)IBA
11/2001
-
12/2000 |
| 2 | 5,21 - 12,17- dimetheneo- 18H- dibenzo(i,o)pyrrolo(3,4- 1)(1,8)diazacyclohexandecine- 18,10(19H)dione,8((dimethylamino)methyl)- 6,7,8,9,10,11- hexahydro,monomethanesulfonateIBA
11/2001
-
12/2000 |
| 1 | Glatiramer Acetate (Copaxone)FDA Link
11/2014 |
| 1 | Type A Botulinum Toxins (Botox)FDA Link
11/2014 |
| 1 | Bromodeoxyuridine (BrdU)IBA
12/2000 |
| 1 | Antineoplastic Agents (Antineoplastics)IBA
12/2000 |
| 1 | Protein Kinase C betaIBA
12/2000 |
| 1 | Cyclin AIBA
12/2000 |
|
Therapy/Procedure
|